Entry - #605231 - BARDET-BIEDL SYNDROME 6; BBS6 - OMIM
# 605231

BARDET-BIEDL SYNDROME 6; BBS6


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
20p12.2 Bardet-Biedl syndrome 6 605231 AR 3 MKKS 604896
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
GROWTH
Weight
- Obesity
HEAD & NECK
Eyes
- Retinitis pigmentosa
- Retinal dystrophy
GENITOURINARY
External Genitalia (Male)
- Hypogenitalism
- Hypospadias
Kidneys
- Structural renal abnormalities
- Lobulated kidneys
- Cystic kidneys
SKELETAL
Hands
- Polydactyly
Feet
- Syndactyly
NEUROLOGIC
Central Nervous System
- Learning disabilities
- Mental retardation
ENDOCRINE FEATURES
- Diabetes mellitus
MOLECULAR BASIS
- Caused by mutation in the MKKS gene (MKKS, 604896.0003)
Bardet-Biedl syndrome - PS209900 - 25 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p35.2 {Bardet-Biedl syndrome 1, modifier of} AR, DR 3 209900 CCDC28B 610162
1q43-q44 Bardet-Biedl syndrome 16 AR 3 615993 SDCCAG8 613524
2p23.3 Bardet-Biedl syndrome 20 AR 3 619471 IFT172 607386
2p15 Bardet-Biedl syndrome 15 AR 3 615992 WDPCP 613580
2q31.1 Bardet-Biedl syndrome 5 AR 3 615983 BBS5 603650
3p21.31 Bardet-Biedl syndrome 17 AR 3 615994 LZTFL1 606568
3q11.2 {Bardet-Biedl syndrome 1, modifier of} AR, DR 3 209900 ARL6 608845
3q11.2 Bardet-Biedl syndrome 3 AR 3 600151 ARL6 608845
4q27 Bardet-Biedl syndrome 7 AR 3 615984 BBS7 607590
4q27 Bardet-Biedl syndrome 12 AR 3 615989 BBS12 610683
7p14.3 Bardet-Biedl syndrome 9 AR 3 615986 PTHB1 607968
8q22.1 {Bardet-Biedl syndrome 14, modifier of} AR 3 615991 TMEM67 609884
8q22.1 Bardet-Biedl syndrome 21 AR 3 617406 CFAP418 614477
9p21.2 Bardet-Biedl syndrome 22 AR 3 617119 IFT74 608040
9q33.1 ?Bardet-Biedl syndrome 11 AR 3 615988 TRIM32 602290
10q25.2 Bardet-Biedl syndrome 18 AR 3 615995 BBIP1 613605
11q13.2 Bardet-Biedl syndrome 1 AR, DR 3 209900 BBS1 209901
12q21.2 Bardet-Biedl syndrome 10 AR 3 615987 BBS10 610148
12q21.32 ?Bardet-Biedl syndrome 14 AR 3 615991 CEP290 610142
14q31.3 Bardet-Biedl syndrome 8 AR 3 615985 TTC8 608132
15q24.1 Bardet-Biedl syndrome 4 AR 3 615982 BBS4 600374
16q13 Bardet-Biedl syndrome 2 AR 3 615981 BBS2 606151
17q22 Bardet-Biedl syndrome 13 AR 3 615990 MKS1 609883
20p12.2 Bardet-Biedl syndrome 6 AR 3 605231 MKKS 604896
22q12.3 Bardet-Biedl syndrome 19 AR 3 615996 IFT27 615870

TEXT

A number sign (#) is used with this entry because Bardet-Biedl syndrome-6 (BBS6) is caused by homozygous or compound heterozygous mutation in the MKKS gene (604896) on chromosome 20p12.

Mutations in the MKKS gene can also cause McKusick-Kaufman syndrome (236700).


Description

Bardet-Biedl syndrome-6 (BBS6) is an autosomal recessive disorder with the cardinal features of postaxial polydactyly, retinitis pigmentosa, kidney defects, obesity, and mental retardation (Slavotinek et al., 2000). Zaghloul and Katsanis (2009) estimated that mutations in the MKKS gene account for 5.8% of the total BBS mutational load.

For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900).


Clinical Features

Slavotinek et al. (2000) described patients from 4 families with BBS6. The first was a 13-year-old Hispanic girl with severe retinitis pigmentosa, postaxial polydactyly, mental retardation, and obesity (BMI greater than 40). A second proband and her affected brother had retinitis pigmentosa, postaxial polydactyly, mild mental retardation, morbid obesity (BMI greater than 50 and 37, respectively), lobulated kidneys with prominent calyces, and diabetes mellitus. A deceased sister had similar phenotypic features and also had vaginal atresia and syndactyly of both feet. A third family included a 4-year-old male proband with reduced visual acuity, postaxial polydactyly, obesity, and cystic kidneys, and a sib with hypospadias, postaxial polydactyly, obesity, and lobular cystic kidneys who died at age 18 months. A fourth family consisted of a female proband diagnosed at age 5 years because of severe retinitis pigmentosa, postaxial polydactyly, morbid obesity, and diabetes mellitus, and a male sib with retinitis pigmentosa, postaxial polydactyly, obesity, lobulated cystic kidneys, and diabetes mellitus.

Scheidecker et al. (2015) reported a 36-year-old patient with BBS6 who had moderately severe cone dystrophy with mildly decreased visual acuity and photophobia.


Inheritance

The transmission pattern of BBS6 in the families reported by Slavotinek et al. (2000) and Katsanis et al. (2000) was consistent with autosomal recessive inheritance.


Molecular Genetics

Slavotinek et al. (2000) and Katsanis et al. (2000) identified homozygous and compound heterozygous mutations in the MKKS gene in patients with BBS6. Slavotinek et al. (2000) ascertained 34 unrelated probands with classic features of BBS including retinitis pigmentosa, obesity, and polydactyly. They found MKKS mutations in 4 typical BBS probands. Three of the probands were from Newfoundland and were also included in the study of Katsanis et al. (2000).

Slavotinek et al. (2000) sought mutations in the MKKS gene because of phenotypic similarities between McKusick-Kaufman syndrome and Bardet-Biedl syndrome. McKusick-Kaufman syndrome (236700) includes hydrometrocolpos, postaxial polydactyly, and congenital heart disease, with autosomal recessive inheritance. Bardet-Biedl syndrome is likewise an autosomal recessive disorder and is characterized by obesity, retinal dystrophy, polydactyly, learning difficulties, hypogenitalism, and renal malformations, with secondary features that include diabetes mellitus.

Katsanis et al. (2000) performed a genome screen in BBS families from Newfoundland in which linkage to known BBS loci had been excluded. Fine mapping reduced the critical interval to a region including the MKKS gene. Given the mapping position and the clinical similarity between McKusick-Kaufman syndrome and Bardet-Biedl syndrome, they screened the MKKS gene and identified mutations in 5 Newfoundland and 2 European-American BBS pedigrees. Most were frameshift mutations, predicted to result in a nonfunctional protein.

Beales et al. (2001) collected a cohort of 163 BBS pedigrees from diverse ethnic backgrounds and evaluated them for mutations in the MKKS gene and for potential assignment of the disorder to any of the other known BBS loci. Using a combination of mutation and haplotype analysis, they described a spectrum of BBS6 alterations that are likely to be pathogenic; proposed substantially reduced critical intervals for BBS2 (209900) on 16q21, BBS3 (608845) on 3p, and BBS5 (603650) on 2q; and presented evidence for the existence of at least one more BBS locus, bringing the total to 7. The data suggested that BBS6 is a minor contributor to the syndrome and that some BBS6 alleles may act in conjunction with mutations at other BBS loci to cause or modify the BBS phenotype.

In a population-based study including 93 BBS patients from 74 families of various ethnicities, Billingsley et al. (2010) determined that the chaperonin-like BBS6, BBS10 (610148), and BBS12 (610683) genes are a major contributor to the disorder. Biallelic mutations in these 3 genes were found in 36.5% of the families: 4 patients had mutations in BBS6, 19 had mutations in BBS10, and 10 had mutations in BBS12. Overall, 26 (68%) of 38 mutations were novel. Six patients had mutations present in more than 1 chaperonin-like BBS gene, and 1 patient with a very severe phenotype had 4 mutations in BBS10. The phenotypes observed were beyond the classic BBS phenotype and overlapped with characteristics of MKKS (236700), including congenital heart defect, vaginal atresia, hydrometrocolpos, and cryptorchidism, and with Alstrom syndrome (203800), including diabetes, hearing loss, liver abnormalities, endocrine anomalies, and cardiomyopathy.


REFERENCES

  1. Beales, P. L., Katsanis, N., Lewis, R. A., Ansley, S. J., Elcioglu, N., Raza, J., Woods, M. O., Green, J. S., Parfrey, P. S., Davidson, W. S., Lupski, J. R. Genetic and mutational analyses of a large multiethnic Bardet-Biedl cohort reveal a minor involvement of BBS6 and delineate the critical intervals of other loci. Am. J. Hum. Genet. 68: 606-616, 2001. Note: Erratum: Am. J. Hum. Genet. 69: 922 only, 2001. [PubMed: 11179009, images, related citations] [Full Text]

  2. Billingsley, G., Bin, J., Fieggen, K. J., Duncan, J. L., Gerth, C., Ogata, K., Wodak, S. S., Traboulsi, E. I., Fishman, G. A., Paterson, A., Chitayat, D., Knueppel, T., Millan, J. M., Mitchell, G. A., Deveault, C., Heon, E. Mutations in chaperonin-like BBS genes are a major contributor to disease development in a multiethnic Bardet-Biedl syndrome patient population. J. Med. Genet. 47: 453-463, 2010. [PubMed: 20472660, related citations] [Full Text]

  3. Katsanis, N., Beales, P. L., Woods, M. O., Lewis, R. A., Green, J. S., Parfrey, P. S., Ansley, S. J., Davidson, W. S., Lupski, J. R. Mutations in MKKS cause obesity, retinal dystrophy and renal malformations associated with Bardet-Biedl syndrome. Nature Genet. 26: 67-70, 2000. [PubMed: 10973251, related citations] [Full Text]

  4. Scheidecker, S., Hull, S., Perdomo, Y., Studer, F., Pelletier, V., Muller, J., Stoetzel, C., Schaefer, E., Defoort-Dhellemmes, S., Drumare, I., Holder, G. E., Hamel, C. P., Webster, A. R., Moore, A. T., Puech, B., Dollfus, H. J. Predominantly cone-system dysfunction as rare form of retinal degeneration in patients with molecularly confirmed Bardet-Biedl syndrome. Am. J. Ophthal. 160: 364-372, 2015. [PubMed: 25982971, related citations] [Full Text]

  5. Slavotinek, A. M., Stone, E. M., Mykytyn, K., Heckenlively, J. R., Green, J. S., Heon, E., Musarella, M. A., Parfrey, P. S., Sheffield, V. C., Biesecker, L. G. Mutations in MKKS cause Bardet-Biedl syndrome. Nature Genet. 26: 15-16, 2000. Note: Erratum: Nature Genet. 28: 193 only, 2001. [PubMed: 10973238, related citations] [Full Text]

  6. Zaghloul, N. A., Katsanis, N. Mechanistic insights into Bardet-Biedl syndrome, a model ciliopathy. J. Clin. Invest. 119: 428-437, 2009. [PubMed: 19252258, images, related citations] [Full Text]


Contributors:
Victor A. McKusick - updated : 3/19/2001
Creation Date:
Victor A. McKusick : 8/28/2000
carol : 08/12/2023
alopez : 06/20/2017
alopez : 06/13/2017
alopez : 06/13/2017
carol : 04/18/2016
alopez : 3/13/2015
ckniffin : 10/27/2014
alopez : 10/16/2014
alopez : 10/5/2001
cwells : 4/5/2001
cwells : 3/29/2001
terry : 3/19/2001
alopez : 8/28/2000
alopez : 8/28/2000

# 605231

BARDET-BIEDL SYNDROME 6; BBS6


ORPHA: 110;   DO: 0110128;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
20p12.2 Bardet-Biedl syndrome 6 605231 Autosomal recessive 3 MKKS 604896

TEXT

A number sign (#) is used with this entry because Bardet-Biedl syndrome-6 (BBS6) is caused by homozygous or compound heterozygous mutation in the MKKS gene (604896) on chromosome 20p12.

Mutations in the MKKS gene can also cause McKusick-Kaufman syndrome (236700).


Description

Bardet-Biedl syndrome-6 (BBS6) is an autosomal recessive disorder with the cardinal features of postaxial polydactyly, retinitis pigmentosa, kidney defects, obesity, and mental retardation (Slavotinek et al., 2000). Zaghloul and Katsanis (2009) estimated that mutations in the MKKS gene account for 5.8% of the total BBS mutational load.

For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900).


Clinical Features

Slavotinek et al. (2000) described patients from 4 families with BBS6. The first was a 13-year-old Hispanic girl with severe retinitis pigmentosa, postaxial polydactyly, mental retardation, and obesity (BMI greater than 40). A second proband and her affected brother had retinitis pigmentosa, postaxial polydactyly, mild mental retardation, morbid obesity (BMI greater than 50 and 37, respectively), lobulated kidneys with prominent calyces, and diabetes mellitus. A deceased sister had similar phenotypic features and also had vaginal atresia and syndactyly of both feet. A third family included a 4-year-old male proband with reduced visual acuity, postaxial polydactyly, obesity, and cystic kidneys, and a sib with hypospadias, postaxial polydactyly, obesity, and lobular cystic kidneys who died at age 18 months. A fourth family consisted of a female proband diagnosed at age 5 years because of severe retinitis pigmentosa, postaxial polydactyly, morbid obesity, and diabetes mellitus, and a male sib with retinitis pigmentosa, postaxial polydactyly, obesity, lobulated cystic kidneys, and diabetes mellitus.

Scheidecker et al. (2015) reported a 36-year-old patient with BBS6 who had moderately severe cone dystrophy with mildly decreased visual acuity and photophobia.


Inheritance

The transmission pattern of BBS6 in the families reported by Slavotinek et al. (2000) and Katsanis et al. (2000) was consistent with autosomal recessive inheritance.


Molecular Genetics

Slavotinek et al. (2000) and Katsanis et al. (2000) identified homozygous and compound heterozygous mutations in the MKKS gene in patients with BBS6. Slavotinek et al. (2000) ascertained 34 unrelated probands with classic features of BBS including retinitis pigmentosa, obesity, and polydactyly. They found MKKS mutations in 4 typical BBS probands. Three of the probands were from Newfoundland and were also included in the study of Katsanis et al. (2000).

Slavotinek et al. (2000) sought mutations in the MKKS gene because of phenotypic similarities between McKusick-Kaufman syndrome and Bardet-Biedl syndrome. McKusick-Kaufman syndrome (236700) includes hydrometrocolpos, postaxial polydactyly, and congenital heart disease, with autosomal recessive inheritance. Bardet-Biedl syndrome is likewise an autosomal recessive disorder and is characterized by obesity, retinal dystrophy, polydactyly, learning difficulties, hypogenitalism, and renal malformations, with secondary features that include diabetes mellitus.

Katsanis et al. (2000) performed a genome screen in BBS families from Newfoundland in which linkage to known BBS loci had been excluded. Fine mapping reduced the critical interval to a region including the MKKS gene. Given the mapping position and the clinical similarity between McKusick-Kaufman syndrome and Bardet-Biedl syndrome, they screened the MKKS gene and identified mutations in 5 Newfoundland and 2 European-American BBS pedigrees. Most were frameshift mutations, predicted to result in a nonfunctional protein.

Beales et al. (2001) collected a cohort of 163 BBS pedigrees from diverse ethnic backgrounds and evaluated them for mutations in the MKKS gene and for potential assignment of the disorder to any of the other known BBS loci. Using a combination of mutation and haplotype analysis, they described a spectrum of BBS6 alterations that are likely to be pathogenic; proposed substantially reduced critical intervals for BBS2 (209900) on 16q21, BBS3 (608845) on 3p, and BBS5 (603650) on 2q; and presented evidence for the existence of at least one more BBS locus, bringing the total to 7. The data suggested that BBS6 is a minor contributor to the syndrome and that some BBS6 alleles may act in conjunction with mutations at other BBS loci to cause or modify the BBS phenotype.

In a population-based study including 93 BBS patients from 74 families of various ethnicities, Billingsley et al. (2010) determined that the chaperonin-like BBS6, BBS10 (610148), and BBS12 (610683) genes are a major contributor to the disorder. Biallelic mutations in these 3 genes were found in 36.5% of the families: 4 patients had mutations in BBS6, 19 had mutations in BBS10, and 10 had mutations in BBS12. Overall, 26 (68%) of 38 mutations were novel. Six patients had mutations present in more than 1 chaperonin-like BBS gene, and 1 patient with a very severe phenotype had 4 mutations in BBS10. The phenotypes observed were beyond the classic BBS phenotype and overlapped with characteristics of MKKS (236700), including congenital heart defect, vaginal atresia, hydrometrocolpos, and cryptorchidism, and with Alstrom syndrome (203800), including diabetes, hearing loss, liver abnormalities, endocrine anomalies, and cardiomyopathy.


REFERENCES

  1. Beales, P. L., Katsanis, N., Lewis, R. A., Ansley, S. J., Elcioglu, N., Raza, J., Woods, M. O., Green, J. S., Parfrey, P. S., Davidson, W. S., Lupski, J. R. Genetic and mutational analyses of a large multiethnic Bardet-Biedl cohort reveal a minor involvement of BBS6 and delineate the critical intervals of other loci. Am. J. Hum. Genet. 68: 606-616, 2001. Note: Erratum: Am. J. Hum. Genet. 69: 922 only, 2001. [PubMed: 11179009] [Full Text: https://doi.org/10.1086/318794]

  2. Billingsley, G., Bin, J., Fieggen, K. J., Duncan, J. L., Gerth, C., Ogata, K., Wodak, S. S., Traboulsi, E. I., Fishman, G. A., Paterson, A., Chitayat, D., Knueppel, T., Millan, J. M., Mitchell, G. A., Deveault, C., Heon, E. Mutations in chaperonin-like BBS genes are a major contributor to disease development in a multiethnic Bardet-Biedl syndrome patient population. J. Med. Genet. 47: 453-463, 2010. [PubMed: 20472660] [Full Text: https://doi.org/10.1136/jmg.2009.073205]

  3. Katsanis, N., Beales, P. L., Woods, M. O., Lewis, R. A., Green, J. S., Parfrey, P. S., Ansley, S. J., Davidson, W. S., Lupski, J. R. Mutations in MKKS cause obesity, retinal dystrophy and renal malformations associated with Bardet-Biedl syndrome. Nature Genet. 26: 67-70, 2000. [PubMed: 10973251] [Full Text: https://doi.org/10.1038/79201]

  4. Scheidecker, S., Hull, S., Perdomo, Y., Studer, F., Pelletier, V., Muller, J., Stoetzel, C., Schaefer, E., Defoort-Dhellemmes, S., Drumare, I., Holder, G. E., Hamel, C. P., Webster, A. R., Moore, A. T., Puech, B., Dollfus, H. J. Predominantly cone-system dysfunction as rare form of retinal degeneration in patients with molecularly confirmed Bardet-Biedl syndrome. Am. J. Ophthal. 160: 364-372, 2015. [PubMed: 25982971] [Full Text: https://doi.org/10.1016/j.ajo.2015.05.007]

  5. Slavotinek, A. M., Stone, E. M., Mykytyn, K., Heckenlively, J. R., Green, J. S., Heon, E., Musarella, M. A., Parfrey, P. S., Sheffield, V. C., Biesecker, L. G. Mutations in MKKS cause Bardet-Biedl syndrome. Nature Genet. 26: 15-16, 2000. Note: Erratum: Nature Genet. 28: 193 only, 2001. [PubMed: 10973238] [Full Text: https://doi.org/10.1038/79116]

  6. Zaghloul, N. A., Katsanis, N. Mechanistic insights into Bardet-Biedl syndrome, a model ciliopathy. J. Clin. Invest. 119: 428-437, 2009. [PubMed: 19252258] [Full Text: https://doi.org/10.1172/JCI37041]


Contributors:
Victor A. McKusick - updated : 3/19/2001

Creation Date:
Victor A. McKusick : 8/28/2000

Edit History:
carol : 08/12/2023
alopez : 06/20/2017
alopez : 06/13/2017
alopez : 06/13/2017
carol : 04/18/2016
alopez : 3/13/2015
ckniffin : 10/27/2014
alopez : 10/16/2014
alopez : 10/5/2001
cwells : 4/5/2001
cwells : 3/29/2001
terry : 3/19/2001
alopez : 8/28/2000
alopez : 8/28/2000